Endovia Health (EDVA) analyst forecast and price target
Analyst forecast
Consensus of 1 analyst rating
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| HC Wainwright & Co. | Maintained | Buy | $0.50 from $1.00 | Nov 29, 2024 |
| Roth MKM | Maintained | Buy | $1.00 | Sep 3, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $1.00 | Aug 26, 2024 |
| Roth MKM | Maintained | Buy | $1.00 from $2.85 | Jun 25, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $1.00 | May 22, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $1.00 from $2.50 | Apr 4, 2024 |
| EF Hutton | Maintained | Buy | $2.50 | Nov 20, 2023 |
| EF Hutton | Maintained | Buy | $2.50 | Sep 14, 2023 |
| HC Wainwright & Co. | Maintained | Buy | $2.50 | Aug 16, 2023 |
| EF Hutton | Maintained | Buy | $2.50 from $3.00 | Aug 15, 2023 |
| HC Wainwright & Co. | Maintained | Buy | $2.50 | Jun 7, 2023 |
Frequently asked questions
Is EDVA a buy, sell, or hold?
Analysts covering Endovia Health currently average a Buy rating: 1 buy, 0 hold and 0 sell, from 1 analyst. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on EDVA?
On Nov 29, 2024, HC Wainwright & Co. maintained Endovia Health at Buy with a price target of $0.50.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.